Clinical Trial Update: Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE [Phase 4]

View source ↗

Summary

Phase 4 trial update studying chemotherapy with Imatinib for young adults with Philadelphia chromosome–positive acute lymphoblastic leukemia (ALLPh+).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia Ph Positive

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Lymphoblastic Leukemia Ph Positive | Phase 4 | Status: UNKNOWN